Growth hormone therapy for children with KBG syndrome: A case report and review of literature
Authors:
Open Access
- 26 March 2020
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 8 (6) , 1172-1179
Abstract
The incidence of short stature in KBG syndrome is relatively high. Data on the therapeutic effects of growth hormone (GH) on children with KBG syndrome accompanied by short stature in the previous literature has not been summarized. Here we studied a girl with KBG syndrome and collected the data of children with KBG syndrome accompanied by short stature from previous studies before and after GH therapy. The girl was referred to our department because of short stature. Physical examination revealed mild dysmorphic features. The peak GH responses to arginine and clonidine were 6.22 and 5.40 ng/mL, respectively. The level of insulin-like growth factor 1 (IGF-1) was 42.0 ng/mL. Genetic analysis showed a c.2635 dupG (p.Glu879fs) mutation in the ANKRD11 gene. She received GH therapy. During the first year of GH therapy, her height increased by 0.92 standard deviation score (SDS). Her height increased from -1.95 SDS to -0.70 SDS after two years of GH therapy. There were ten children with KBG syndrome accompanied by short stature who received GH therapy in reported cases. Height SDS was improved in nine (9/10) of them. The mean height SDS in five children with KBG syndrome accompanied by short stature increased from -2.72 ± 0.44 to -1.95 ± 0.57 after the first year of GH therapy (P = 0.001). There were no adverse reactions reported after GH treatment. GH treatment is effective in our girl and most children with KBG syndrome accompanied by short stature during the first year of therapy.Keywords
This publication has 12 references indexed in Scilit:
- Novel Mutations and Unreported Clinical Features in KBG SyndromeMolecular Syndromology, 2019
- KBG syndrome: An Australian experienceAmerican Journal of Medical Genetics Part A, 2017
- Clinical and genetic aspects of KBG syndromeAmerican Journal of Medical Genetics Part A, 2016
- Short Stature in KBG Syndrome: First Responses to Growth Hormone TreatmentHormone Research in Paediatrics, 2015
- Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndromeAmerican Journal of Medical Genetics Part A, 2013
- Specific-site methylation of tumour suppressor ANKRD11 in breast cancerEuropean Journal of Cancer, 2012
- Mutations in ANKRD11 Cause KBG Syndrome, Characterized by Intellectual Disability, Skeletal Malformations, and MacrodontiaThe American Journal of Human Genetics, 2011
- Identification of ANKRD11 as a p53 coactivatorJournal of Cell Science, 2008
- The KBG syndrome: Confirmation of autosomal dominant inheritance and further delineation of the phenotypeAmerican Journal of Medical Genetics Part A, 2004
- The KBG syndrome-a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies.1975